Humana Cash & Equivalents increased by 17.9% to $4.95B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.5%, from $4.25B to $4.95B. Over 4 years (FY 2021 to FY 2025), Cash & Equivalents shows an upward trend with a 5.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase signals improved liquidity and financial flexibility, while a decrease may indicate heavy capital expenditure, debt repayment, or aggressive share buybacks.
Represents the most liquid assets on the balance sheet, including physical currency and short-term investments with matu...
Large-cap technology peers often maintain high cash balances to fund rapid innovation and offset the cyclical nature of consumer electronics.
cash_and_equivalents| Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.39B | $4.86B | $5.22B | $5.06B | $13.74B | $16.21B | $15.15B | $4.69B | $5.91B | $5.50B | $5.12B | $2.22B | $4.25B | $4.04B | $5.39B | $4.20B | $4.95B |
| QoQ Change | — | +43.3% | +7.3% | -3.0% | +171.4% | +18.0% | -6.6% | -69.0% | +25.9% | -6.9% | -7.0% | -56.6% | +91.4% | -4.9% | +33.4% | -22.0% | +17.9% |
| YoY Change | — | — | — | +49.1% | +182.4% | +210.6% | — | -7.3% | -57.0% | -66.1% | -66.2% | -52.7% | -28.1% | -26.6% | +5.3% | +89.1% | +16.5% |